# RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission

> **NCT02878200** · NA · COMPLETED · sponsor: **London School of Hygiene and Tropical Medicine** · enrollment: 2236 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT02878200
- **Lead sponsor:** London School of Hygiene and Tropical Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-04
- **Primary completion:** 2018-12-18
- **Final completion:** 2020-07-16
- **Target enrollment:** 2236 (ACTUAL)
- **Last updated:** 2020-09-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02878200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02878200, "RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02878200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*